11&bgr;-Hydroxysteroid Dehydrogenase Type 1 Inhibitors as Promising Therapeutic Drugs for Diabetes: Status and Development

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|17|5|412-422

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.17, Iss.5, 2010-02, pp. : 412-422

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Type 1 11 &bgr;-hydroxysteroid Dehydrogenase as Universal Drug Target in Metabolic Diseases?

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 6, Iss. 3, 2006-09 ,pp. : 259-269

Bentham Science Publishers

Access to resources Recommend Favorite

11β-Hydroxysteroid dehydrogenase type 1 inhibitors as therapeutic agents

By Webster Scott Peter   Pallin Thomas David  

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 12, 2007-12 ,pp. : 1407-1422

Informa Healthcare

Access to resources Recommend Favorite

Design, Synthesis and In Vitro Evaluation of 4-Androstene-3,17-dione/Adenosine Hybrid Compounds as Bisubstrate Inhibitors of Type 3 17&bgr;-Hydroxysteroid Dehydrogenase

By  

Medicinal Chemistry, Vol. 2, Iss. 4, 2006-01 ,pp. : 329-347

Bentham Science Publishers

Access to resources Recommend Favorite

11β-Hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of type 2 diabetes

By Morgan Stuart A   Tomlinson Jeremy W  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 9, 2010-09 ,pp. : 1067-1076

Informa Healthcare

Access to resources Recommend Favorite

Small Molecule 11&bgr;- Hydroxysteroid Dehydrogenase Type 1 Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 12, 2011-06 ,pp. : 1464-1475

Bentham Science Publishers

Access to resources Recommend Favorite